News 2019



Results 1 - 17 of 17.

Health - Pharmacology - 15.01.2019
Researcher uses big data to help optimize cancer treatment
In this Q&A, Paul Boutros explains how scientists take data, such as DNA sequencing, to design personal treatments Denise Heady Treating cancer is incredibly complex and there is no one-size-fits-all solution. But, there is something that can help physicians create treatments customized for individuals: big data.

Pharmacology - Health - 15.01.2019
Elephantiasis and river blindness could be eliminated faster with new molecule
A new potential drug molecule could reduce treatment times for two widespread diseases from weeks to days, ultimately helping to eliminate them. The new molecule has been designed to more effectively target and kill the cause of elephantiasis and river blindness while having potentially fewer side effects.

Pharmacology - Health - 15.01.2019
Human hazards hamper vampire bat venom research
Vampire bats could hold the key to new treatments for a range of serious medical problems, but researchers have hit a snag accessing the specimens needed to advance their work. An international team led by The University of Queensland has found a new class of blood pressure-regulating peptides in the venom of the common vampire bat ( Diphylla ecaudata ).

Health - Pharmacology - 14.01.2019
Conversion of breast cancer cells into fat cells impedes the formation of metastases
Conversion of breast cancer cells into fat cells impedes the formation of metastases
An innovative combination therapy can force malignant breast cancer cells to turn into fat cells. This can be used to prevent the formation of metastases in mice, as researchers at the University of Basel's Department of Biomedicine recently reported in the journal Cancer Cell. Tumor cells can adapt dynamically to changing conditions thanks to their ability to reactivate a cellular process that is central to embryonic development.

Pharmacology - Health - 14.01.2019
University launches first-of-its-kind equipment to transform imaging of cells, tissues and materials
The University of Nottingham is the first university in the world to own and operate unique equipment which allows label-free chemical imaging of materials, cells and tissues, with the potential to transform research in these areas. The new 3DOrbiSIMS is the first production instrument of its kind and will have applications in a multi-disciplinary range of research areas, including biomedical implants, drug delivery systems, developing strategies to tackle antimicrobial resistance, organic electronic devices and engineering applications.

Pharmacology - Health - 14.01.2019
New report reveals stark north south divide in painkiller prescribing
A new report has revealed that patients in the north of the country are being prescribed almost four times more opioids to relieve pain than those in the south. The research by the University of Nottingham's School of Pharmacy and the University of Manchester is the first national study to examine the regional variations in opioid prescribing and how this links with socioeconomic status.

Health - Pharmacology - 14.01.2019
Herbal antioxidants are becoming increasingly important
Herbal antioxidants are becoming increasingly important
Secondary plant compounds as an alternative to antioxidant vitamins and minerals The human organism is constantly exposed to so-called free radicals, which are a burden on the body. If they get out of hand, the result is oxidative stress, which can promote disease. While this has been treated in the past with the help of antioxidant vitamins and minerals, scientists are now increasingly turning to the use of phytochemicals, representing plant secondary metabolites.

Pharmacology - Health - 11.01.2019
Discreet contraception for world’s poorest countries
Innovative microneedle technology is being developed as an effective, pain-free and discreet method of delivering contraception across the world's poorest countries, thanks to a new research consortium led by Cardiff University and supported by the Bill & Melinda Gates Foundation. The project will focus on pre-clinical work to develop microneedle patches that have the potential to be painlessly and inconspicuously administered by the user themselves within a few seconds and can last for up to six months.

Health - Pharmacology - 10.01.2019
New drug against the formation of metastasis
New drug against the formation of metastasis
The most deadly aspect of breast cancer is metastasis. It spreads cancer cells throughout the body. Researchers at the University and the University Hospital of Basel have now discovered a substance that suppresses the formation of metastases. The development of metastasis is responsible for more than 90% of cancer-related deaths, and patients with a metastatic disease are considered incurable.

Pharmacology - Life Sciences - 10.01.2019
How Drugs Can Minimize the Side Effects of Chemotherapy
Researchers at the University of Zurich have determined the three-dimensional structure of the receptor that causes nausea and vomiting as a result of cancer chemotherapy. The study explains for the first time why some drugs work particularly well in ameliorating these side effects. The results also provide important insights into how to develop compounds to effectively tackle other disorders.

Health - Pharmacology - 09.01.2019
HRT tablets increase risk of blood clots in women
Women who use certain types of hormone replacement therapy (HRT) are at a higher risk of developing potentially life-threatening blood clots, new research has confirmed. The study, undertaken by researchers at The University of Nottingham and published in the BMJ , found that the risk of developing blood clots was only increased for women using HRT in tablet form and was slightly higher for higher dosages.

Pharmacology - Life Sciences - 08.01.2019
Anticancer Drugs Formed through Molecular Evolution
Scientists at Freie Universität Explore Alternative Routes to Drugs against Tumor Cells / Findings published in online journal "Nature Communications" No 002/2019 from Jan 08, 2019 Scientists at Freie Universität Berlin have discovered an alternative route to drugs against tumor cells. The group led by Jörg Rademann from the Institute of Pharmacy examined the protein STAT5, which is responsible for the aggressive growth of human leukemia cells.

Health - Pharmacology - 07.01.2019
Automated phone calls may help patients to take medicines as prescribed, pilot study suggests
Automated phone calls may help patients to take medicines as prescribed, pilot study suggests
Remembering to take medication is vital for managing long term health conditions such as high blood pressure, type 2 diabetes, or multiple conditions. Latest research from the University of Cambridge suggests that using interactive voice response (IVR) technology supports patients to take their medicine as prescribed.

Pharmacology - Life Sciences - 07.01.2019
Gene map offers osteoporosis hope
An atlas of genetic markers may hold the key to unlocking new treatments for osteoporosis, thanks to University of Queensland researchers. The team identified more than 500 genetic markers which determine bone mineral density, one of the strongest risk factors for osteoporosis. Researchers hope the atlas will lead to the development of treatments by highlighting a select set of genes.

Pharmacology - Health - 04.01.2019
Engineers create an inhalable form of messenger RNA
Engineers create an inhalable form of messenger RNA
Patients with lung disease could find relief by breathing in messenger RNA molecules. Messenger RNA, which can induce cells to produce therapeutic proteins, holds great promise for treating a variety of diseases. The biggest obstacle to this approach so far has been finding safe and efficient ways to deliver mRNA molecules to the target cells.

Life Sciences - Pharmacology - 03.01.2019
A new ’atlas’ of genetic influences on osteoporosis
Identifying more than 500 genetic determinants of bone mineral density, researchers expect to provide new opportunities for the development of novel drugs to prevent or treat osteoporosis A ground-breaking new study led by researchers from the Lady Davis Institute (LDI) at the Jewish General Hospital (JGH) has succeeded in compiling an atlas of genetic factors associated with estimated bone mineral density (BMD), one of the most clinically relevant factors in diagnosing osteoporosis.

Health - Pharmacology - 02.01.2019
Tumors backfire on chemotherapy
Chemotherapy is an effective treatment for breast cancer, yet some patients develop metastasis in spite of it. Researchers at EPFL have discovered that chemotherapy-treated mammary tumors produce small vesicles that may help them spread to other organs. The study is published. Some patients with breast cancer receive chemotherapy before the tumor is removed with surgery.